HPS-042 - Drug-drug interactions in the treatment of chronic comorbidities and effects on the patient management: Type 2 Diabetes and Chronic Coronary Syndromes

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-042
• By: LIU, Xiaoyan (Department of Pharmacy, Fudan University Shanghai Cancer Center, China)
• Co-author(s): Ms Qingqing Chai (Department of Pharmacy, Huadong Hospital, Fudan University, Shanghai, China / Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai, China)
  Dr Xiaoyan Liu (Department of Pharmacy, Huadong Hospital, Fudan University, Shanghai, China)
  
• Abstract:

  Introduction: The ageing population means more comorbidities and generally more Drug-drug interactions (DDIs) to be managed. Complications of diabetes are important, and patients with these comorbidities are often treated with multiple drugs. Type 2 diabetes mellitus and chronic coronary syndromes frequently coexist in older adults with..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login